Biological E. today announced that it has reduced the price of its Covid-19 vaccine Corbevax, from Rs.840 to Rs.250 a dose inclusive of GST, for private Covid-19 vaccination centres. For the end-user, the price would be Rs.400 a dose, including taxes and administration charges. 

 BE has lowered the price of its vaccine with the aim of making it more affordable and helping increase the reach to protect the maximum number of children against the virus. The decision comes within weeks of Biological E. receiving Emergency Use Authorization (EUA) for children between 5 and 12 years of age. The previous private market price for the vaccine was Rs.990 a dose including taxes and vaccine administration charges. 

Corbevax is also offered in a single-dose vial, making it more convenient for vaccine administration. It eliminates vaccine wastage, which is a major advantage for private hospitals. 

Biological E in collaboration with Texas Children's Hospital and Baylor College of Medicine, has developed a recombinant protein sub-unit vaccine for the novel coronavirus, Corbevax prior to receiving EUA for vaccination, the company conducted Phase II and III multicentre clinical trials in 624 children aged 5-12 and 12-18.